Tulobuterol Hydrochloride/Bromhexine Hydrochloride/Promethazine Hydrochloride

盐酸丁氯喘/盐酸溴己新/盐酸异丙嗪

Report date: 2022/09/05 11:29:56

Base Information

Drug NameTulobuterol Hydrochloride/Bromhexine Hydrochloride/Promethazine Hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionBeta-2 adrenergic receptor agonistsHistamine H1 receptor antagonists
TargetsBeta-2 adrenergic receptorHistamine H1 receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A